• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在撒哈拉以南非洲地区推广检测不出即无法传播:对临床实践和抗逆转录病毒治疗依从性的影响。

Promoting ndetectable Equals ntransmittable in Sub-Saharan Africa: Implication for Clinical Practice and ART Adherence.

机构信息

Division of Human Genetics, Department of Pathology & Institute for Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Anzio Road, Observatory, Cape Town 7925, South Africa.

School of Medical Sciences, College of Health and Allied Sciences, University of Cape Coast, Cape Coast, Ghana.

出版信息

Int J Environ Res Public Health. 2020 Aug 25;17(17):6163. doi: 10.3390/ijerph17176163.

DOI:10.3390/ijerph17176163
PMID:32854292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7503341/
Abstract

In the last decade, reliable scientific evidence has emerged to support the concept that undetectable viral loads prevent human immunodeficiency virus (HIV). Undetectable equals untransmissible (U = U) is a simple message that everyone can understand. The success of this concept depends on strict adherence to antiretroviral therapy (ART) and the attainment of suppressed viral loads (VLs). To achieve U = U in sub-Saharan Africa (SSA), poor adherence to ART, persistent low-level viremia, and the emergence of drug-resistant mutants are challenges that cannot be overlooked. Short of a cure for HIV, U = U can substantially reduce the burden and change the landscape of HIV epidemiology on the continent. From a public health perspective, the U = U concept will reduce stigmatization in persons living with HIV (PLWHIV) in SSA and strengthen public opinion to accept that HIV infection is not a death sentence. This will also promote ART adherence because PLWHIV will aim to achieve U = U within the shortest possible time. This article highlights challenges and barriers to achieving U = U and suggests how to promote the concept to make it beneficial and applicable in SSA. This concept, if expertly packaged by policy-makers, clinicians, health service providers, and HIV control programs, will help to stem the tide of the epidemic in SSA.

摘要

在过去的十年中,可靠的科学证据已经出现,支持了无法检测到的病毒载量可预防人类免疫缺陷病毒(HIV)这一概念。无法检测到等于无法传播(U=U),这是一个每个人都能理解的简单信息。这一概念的成功取决于对抗逆转录病毒疗法(ART)的严格遵守和实现抑制病毒载量(VL)。要在撒哈拉以南非洲(SSA)实现 U=U,对 ART 的坚持、持续的低水平病毒血症以及耐药突变体的出现是不容忽视的挑战。在 HIV 治愈方法问世之前,U=U 可以大大减轻该大陆的 HIV 流行病学负担并改变其面貌。从公共卫生的角度来看,U=U 这一概念将减少撒哈拉以南非洲地区 HIV 感染者(PLWHIV)的污名化,并加强公众对 HIV 感染并非死刑的接受程度。这也将促进 ART 的坚持,因为 PLWHIV 将努力在尽可能短的时间内实现 U=U。本文重点介绍了实现 U=U 所面临的挑战和障碍,并提出了如何推广这一概念,使其在 SSA 地区受益和适用。如果政策制定者、临床医生、卫生服务提供者和 HIV 控制项目巧妙地包装这一概念,将有助于遏制 SSA 地区的疫情蔓延。

相似文献

1
Promoting ndetectable Equals ntransmittable in Sub-Saharan Africa: Implication for Clinical Practice and ART Adherence.在撒哈拉以南非洲地区推广检测不出即无法传播:对临床实践和抗逆转录病毒治疗依从性的影响。
Int J Environ Res Public Health. 2020 Aug 25;17(17):6163. doi: 10.3390/ijerph17176163.
2
Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.撒哈拉以南非洲地区感染艾滋病毒青少年的流行病学和抗逆转录病毒药物依从性的当代问题:一项叙述性综述。
J Int AIDS Soc. 2015 Sep 16;18(1):20049. doi: 10.7448/IAS.18.1.20049. eCollection 2015.
3
Barriers and facilitators to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: A mixed-methods systematic review and meta-analysis.撒哈拉以南非洲地区 10 至 19 岁感染艾滋病毒青少年抗逆转录病毒治疗依从性的障碍和促进因素:一项混合方法系统评价和荟萃分析。
PLoS One. 2023 May 18;18(5):e0276411. doi: 10.1371/journal.pone.0276411. eCollection 2023.
4
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.在撒哈拉以南非洲,强化蛋白酶抑制剂单药治疗与强化蛋白酶抑制剂联合拉米夫定双药治疗作为 HIV-1 感染患者二线维持治疗的比较(ANRS12 286/MOBIDIP):一项多中心、随机、平行、开放标签、优效性试验。
Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.
5
Beyond "Option B+": Understanding Antiretroviral Therapy (ART) Adherence, Retention in Care and Engagement in ART Services Among Pregnant and Postpartum Women Initiating Therapy in Sub-Saharan Africa.超越“方案B+”:了解撒哈拉以南非洲地区开始接受治疗的孕妇和产后妇女的抗逆转录病毒疗法(ART)依从性、治疗留存率及参与ART服务情况
J Acquir Immune Defic Syndr. 2017 Jun 1;75 Suppl 2:S115-S122. doi: 10.1097/QAI.0000000000001343.
6
Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.撒哈拉以南非洲和亚洲地区艾滋病毒抗逆转录病毒治疗的依从性:两个区域队列的比较分析。
J Int AIDS Soc. 2017 Mar 3;20(1):21218. doi: 10.7448/IAS.20.1.21218.
7
HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018.抗逆转录病毒疗法患者的 HIV 病毒载量监测 - 2013-2018 年 8 个撒哈拉以南非洲国家。
MMWR Morb Mortal Wkly Rep. 2021 May 28;70(21):775-778. doi: 10.15585/mmwr.mm7021a2.
8
Non-persistence to antiretroviral therapy among adults receiving HIV medical care in the United States.美国接受艾滋病病毒医疗护理的成年人中抗逆转录病毒治疗的非持续性
AIDS Care. 2019 May;31(5):599-608. doi: 10.1080/09540121.2018.1533232. Epub 2018 Oct 11.
9
Factors impacting antiretroviral therapy adherence among human immunodeficiency virus-positive adolescents in Sub-Saharan Africa: a systematic review.撒哈拉以南非洲地区人类免疫缺陷病毒阳性青少年抗逆转录病毒治疗依从性的影响因素:系统评价。
Public Health. 2018 Apr;157:20-31. doi: 10.1016/j.puhe.2017.12.010. Epub 2018 Mar 20.
10
Antiretroviral therapy related adverse effects: Can sub-Saharan Africa cope with the new "test and treat" policy of the World Health Organization?抗逆转录病毒疗法相关不良反应:撒哈拉以南非洲能否应对世界卫生组织新的“检测即治疗”政策?
Infect Dis Poverty. 2017 Feb 15;6(1):24. doi: 10.1186/s40249-017-0240-3.

引用本文的文献

1
Experiences of undetectable = untransmittable among couples with different HIV serostatus: a qualitative study in Tanzania and Uganda.不同艾滋病毒血清学状态夫妇中“检测不到即不具传染性”的经历:坦桑尼亚和乌干达的一项定性研究
BMC Public Health. 2025 Aug 20;25(1):2854. doi: 10.1186/s12889-025-24120-1.
2
Biomedical Interventions for HIV Prevention and Control: Beyond Vaccination.用于艾滋病毒预防和控制的生物医学干预措施:超越疫苗接种
Viruses. 2025 May 26;17(6):756. doi: 10.3390/v17060756.
3
Barriers to ART adherence in sub-Saharan Africa: a scoping review toward achieving UNAIDS 95-95-95 targets.撒哈拉以南非洲地区抗逆转录病毒治疗依从性的障碍:一项旨在实现联合国艾滋病规划署95-95-95目标的范围综述
Front Public Health. 2025 Jun 10;13:1609743. doi: 10.3389/fpubh.2025.1609743. eCollection 2025.
4
Prevalence and Determinants of Viral Suppression in Young People Living with HIV on Antiretroviral Therapy in Southern Africa: A Cross-Sectional Analysis of HIV Survey Data of 2020 and 2021.南非接受抗逆转录病毒治疗的年轻HIV感染者病毒抑制的流行情况及决定因素:2020年和2021年HIV调查数据的横断面分析
AIDS Behav. 2025 Jun;29(6):1962-1972. doi: 10.1007/s10461-025-04662-6. Epub 2025 Mar 3.
5
Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.交互式语音应答-呼叫生命 mHealth 工具对艾滋病毒感染者青少年抗逆转录病毒治疗依从性的影响:乌干达的一项随机试验。
PLoS One. 2024 Nov 19;19(11):e0308923. doi: 10.1371/journal.pone.0308923. eCollection 2024.
6
The Relationship Between HIV/AIDS Knowledge and Stigmatizing Attitudes Towards People Living with HIV/AIDS: An Educational Intervention Study.艾滋病知识与对艾滋病病毒感染者的污名化态度之间的关系:一项教育干预研究。
Risk Manag Healthc Policy. 2024 Nov 9;17:2755-2762. doi: 10.2147/RMHP.S489989. eCollection 2024.
7
The Perils of Overly Sensitive Viral Load Testing for Persons With Human Immunodeficiency Virus.人类免疫缺陷病毒感染者过度敏感的病毒载量检测的风险
Open Forum Infect Dis. 2023 Oct 3;10(10):ofad494. doi: 10.1093/ofid/ofad494. eCollection 2023 Oct.
8
High prevalence of risky sexual behaviour among key populations receiving antiretroviral therapy at a large HIV clinic in northern Uganda.在乌干达北部的一家大型艾滋病诊所接受抗逆转录病毒治疗的关键人群中,高危性行为的高发率。
Afr Health Sci. 2023 Mar;23(1):362-372. doi: 10.4314/ahs.v23i1.38.
9
The risk of sexual transmission of HIV in individuals with low-level HIV viraemia: a systematic review.个体低水平 HIV 病毒血症患者的 HIV 性传播风险:系统综述。
Lancet. 2023 Aug 5;402(10400):464-471. doi: 10.1016/S0140-6736(23)00877-2. Epub 2023 Jul 22.
10
Psychometric assessment of HIV stigma in patients attending a tertiary facility: An initial validation of the Berger HIV stigma scale in a Ghanaian perspective.在一家三级医疗机构中接受治疗的艾滋病病毒感染者的艾滋病耻辱感的心理评估:在加纳视角下对 Berger 艾滋病耻辱感量表的初步验证。
PLoS One. 2023 Apr 27;18(4):e0282193. doi: 10.1371/journal.pone.0282193. eCollection 2023.

本文引用的文献

1
"I just believe there is a risk" understanding of undetectable equals untransmissible (U = U) among health providers and HIV-negative partners in serodiscordant relationships in Kenya.“我只是认为存在风险”,在肯尼亚的血清不一致关系中,卫生提供者和 HIV 阴性伴侣对无法检测到等于无法传播(U=U)的理解。
J Int AIDS Soc. 2020 Mar;23(3):e25466. doi: 10.1002/jia2.25466.
2
The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings.资源匮乏环境下,CD4 和病毒载量检测未能改善 HIV 感染者的临床转归,错失了大好机会。
PLoS Med. 2019 May 29;16(5):e1002820. doi: 10.1371/journal.pmed.1002820. eCollection 2019 May.
3
The Continuing Value of CD4 Cell Count Monitoring for Differential HIV Care and Surveillance.CD4细胞计数监测在HIV差异化护理和监测中的持续价值
JMIR Public Health Surveill. 2019 Mar 20;5(1):e11136. doi: 10.2196/11136.
4
How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?在南非的凯萨蒂沙,常规报告的 HIV 病毒载量抑制比例在多大程度上反映了接受抗逆转录病毒治疗的人群在实现 90-90-90 目标方面的进展?
S Afr Med J. 2019 Feb 26;109(3):174-177. doi: 10.7196/SAMJ.2019.v109i3.13456.
5
HIV-1 reservoirs in urethral macrophages of patients under suppressive antiretroviral therapy.在接受抑制性抗逆转录病毒治疗的患者的尿道巨噬细胞中存在 HIV-1 储库。
Nat Microbiol. 2019 Apr;4(4):633-644. doi: 10.1038/s41564-018-0335-z. Epub 2019 Feb 4.
6
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable.HIV病毒载量与HIV感染的传播性:检测不到即无传染性。
JAMA. 2019 Feb 5;321(5):451-452. doi: 10.1001/jama.2018.21167.
7
Treating all people living with HIV in sub-Saharan Africa: a new era calling for new approaches.治疗撒哈拉以南非洲地区所有艾滋病毒感染者:新时代呼唤新方法。
J Virus Erad. 2018 Nov 15;4(Suppl 2):1-4. doi: 10.1016/S2055-6640(20)30340-X.
8
Risk of sexual transmission of human immunodeficiency virus with antiretroviral therapy, suppressed viral load and condom use: a systematic review.抗逆转录病毒疗法、病毒载量抑制和使用避孕套与人类免疫缺陷病毒性传播风险:系统评价。
CMAJ. 2018 Nov 19;190(46):E1350-E1360. doi: 10.1503/cmaj.180311.
9
Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Efavirenz 400 mg Once Daily During Pregnancy and Post-Partum.依非韦伦 400 毫克每日一次在孕期和产后的药代动力学、药效学和药物遗传学。
Clin Infect Dis. 2018 Aug 16;67(5):785-790. doi: 10.1093/cid/ciy161.
10
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.在可持续发展目标时代推进全球健康并加强艾滋病应对:国际艾滋病学会-《柳叶刀》委员会
Lancet. 2018 Jul 28;392(10144):312-358. doi: 10.1016/S0140-6736(18)31070-5. Epub 2018 Jul 20.